Payments to Acquire Property, Plant, and Equipment of Cidara Therapeutics, Inc. from 31 Mar 2014 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Cidara Therapeutics, Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Mar 2014 to 31 Mar 2025.
  • Cidara Therapeutics, Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Cidara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $129,000, a 74% decline from 2023.
  • Cidara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $505,000, a 328% increase from 2022.
  • Cidara Therapeutics, Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $118,000, a 188% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Cidara Therapeutics, Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$23,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q1 2024 $23,000 -$71,000 -76% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $94,000 +$10,000 +12% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q1 2022 $84,000 +$72,000 +600% 01 Jan 2022 31 Mar 2022 10-K 22 Apr 2024 2023 FY
Q1 2021 $12,000 -$24,000 -67% 01 Jan 2021 31 Mar 2021 10-Q 11 May 2022 2022 Q1
Q1 2020 $36,000 +$27,000 +300% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $9,000 -$22,000 -71% 01 Jan 2019 31 Mar 2019 10-Q 13 May 2020 2020 Q1
Q1 2018 $31,000 -$85,000 -73% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q1 2017 $116,000 +$62,000 +115% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018 2018 Q1
Q1 2016 $54,000 +$23,000 +74% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017 2017 Q1
Q1 2015 $31,000 +$30,000 +3000% 01 Jan 2015 31 Mar 2015 10-Q 12 May 2016 2016 Q1
Q1 2014 $1,000 01 Jan 2014 31 Mar 2014 10-Q 21 May 2015 2015 Q1

Cidara Therapeutics, Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $129,000 -$376,000 -74% 01 Jan 2024 31 Dec 2024 10-K 06 Mar 2025 2024 FY
2023 $505,000 +$387,000 +328% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $118,000 +$77,000 +188% 01 Jan 2022 31 Dec 2022 10-K 22 Apr 2024 2023 FY
2021 $41,000 -$145,000 -78% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023 2022 FY
2020 $186,000 +$151,000 +431% 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2023 2022 FY
2019 $35,000 -$142,000 -80% 01 Jan 2019 31 Dec 2019 10-K 07 Mar 2022 2021 FY
2018 $177,000 -$129,000 -42% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $306,000 -$95,000 -24% 01 Jan 2017 31 Dec 2017 10-K 04 Mar 2020 2019 FY
2016 $401,000 -$769,000 -66% 01 Jan 2016 31 Dec 2016 10-K 28 Feb 2019 2018 FY
2015 $1,170,000 +$179,000 +18% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018 2017 FY
2014 $991,000 01 Jan 2014 31 Dec 2014 10-K 15 Mar 2017 2016 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.